Please login to the form below

Not currently logged in

Novo Nordisk launches new US insulin campaign

US IndyCar driver, diabetic and FlexPen user Charlie Kimball fronts activities


Novo Nordisk has launched a campaign featuring IndyCar Series driver Charlie Kimball.

Agencies supporting the campaign include Tip Nunn, Chip Ganassi Racing and New York-based Marina Maher Communications, whose client case studies include Merck & Co and Pfizer. 

Diagnosed with diabetes during a routine visit to a GP while racing in Europe in 2007, Kimball is the first licensed driver with diabetes to race at the highest level of the series.

The campaign features a website hosting a competition inviting entrants to build a 'pit crew' by enrolling two friends by email and be in with a chance of winning a VIP trip to the 2013 IndyCar finale and a Twitter feed. Campaign information booths will also be displayed at US racing venues.

A keen advocate of the notion that good management of diabetes is a team effort, Kimball says that it was working as a team that enables him to stay healthy on the track.

Kimball, who has a continuous blood sugar monitor said: ”It takes an entire crew to help me manage both my car and my diabetes, so we can compete at the highest levels”. “This programme is a great way for people to show support, especially for friends and family affected by diabetes, and encourage them to share my story.”

25th April 2013

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....